Antimicrobial drug resistance is a global health problem that continues to expand as micro-organisms adapt to the antibiotics we use to treat them and as new classes of antimicrobial agents have been harder to discover and advance into the clinic. The second edition of Antimicrobial Drug Resistance grew out of a desire by the editors and authors to provide an updated, comprehensive resource of information on antimicrobial drug resistance that would encompass the current information available for bacteria, fungi, protozoa, and viruses. The two volumes have been extensively revised with many new authors and chapters as the field of drug resistance has evolved. Volume 2 addresses clinical, epidemiologic, and public health aspects of drug resistance, along with an overview of the conduct and interpretation of specific drug resistance assays. Together, these two volumes offer a comprehensive source of information on drug resistance issues by the experts in each topic.
|Title of host publication||Antimicrobial drug resistance|
|Subtitle of host publication||Clinical and epidemiological aspects|
|Editors||Douglas Mayers, Jack Sobel, Marc Ouellette, Keith Kaye, Dror Marchaim|
|Place of Publication||Cham, Switzerland|
|Number of pages||21|
|Publication status||Published - 2017|